Floatz logo

DEXKETOPROFEN

Cirrhosis, Liver

M.D. Anderson Cancer CenterSmall moleculeN/AActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
81/ 100

Competitive context

23 Active assets in the Cirrhosis, Liver cohort.

Asset / SponsorPhaseRating
SOMATOSTATIN
General Hospital of Shenyang Military Region
Phase 4BB
Methylene Blue
Institute of Liver and Biliary Sciences, India
Phase 4BB
Ceftriaxone
Shahida Islam Medical Complex
Phase 4BB
NORMAL HUMAN SERUM ALBUMIN
Rush University Medical Center
Phase 4BB
Plavix
M.D. Anderson Cancer Center
Phase 2/3BB

View all 42 →

Same molecule, other indications

DEXKETOPROFEN is also rated in:

migraine disorderDormant
BBB
Indicative ·
73 / 100
View asset →
migraine without auraDormant
BB
Indicative ·
68 / 100
View asset →
Carcinoma, HepatocellularDormant
BB
Indicative ·
67 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →